[go: up one dir, main page]

Fisher et al., 1992 - Google Patents

Why we do what we do: Hypertonic saline for elevated intracranial pressure By Brad Sobolewski, MD, MEd| 2021-03-10T11: 21: 07-05: 00 March 10th, 2021 …

Fisher et al., 1992

View HTML
Document ID
4033030237219166303
Author
Fisher B
Thomas D
Peterson B
Publication year
Publication venue
J Neurosurg Anesthesiol

External Links

Snippet

Technically hypertonic saline is any sodium chloride solution with a greater concentration than normal saline (0.9%, which has 154 mEq/L of NaCl). Available concentrations include 3%(513 mEq/L), 5%(856 mEq/L) and 23.4%(4000 mEq/L). Believe it or not the blood brain …
Continue reading at pemcincinnati.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor

Similar Documents

Publication Publication Date Title
Baumgarten et al. Depletion and accumulation of potassium in the extracellular clefts of cardiac Purkinje fibers during voltage clamp hyperpolarization and depolarization
Tasaki et al. Resting and action potential of intracellularly perfused squid giant axon
CO4700482A1 (en) FORMULATIONS OF A MONOMER INSULIN ANALOG
DE3784916D1 (en) GLUCOSE-FREE MEDIA FOR STORING BLOOD PLATES.
ES8505405A1 (en) Novel purified plasminogen activator, process for its production and thrombolytic composition containing it.
EP0520112A1 (en) Dermatological composition based on an aqueous phase
YU54499A (en) Pharmaceutical compositions for application to mucosa
CA2017265A1 (en) Cosmetic composition against ageing of the skin
Fisher et al. Why we do what we do: Hypertonic saline for elevated intracranial pressure By Brad Sobolewski, MD, MEd| 2021-03-10T11: 21: 07-05: 00 March 10th, 2021| Neurology, Neurosurgery, Trauma, What We Do|
Fisher et al. Why we do what we do: Hypertonic saline for elevated intracranial pressure By Brad Sobolewski, MD, MEd| 2019-12-02T13: 03: 28-05: 00 May 3rd, 2017| Neurology, Neurosurgery, Resuscitation, Trauma, What We Do|
ES2172332T3 (en) USE OF ISOOSMOTIC SALT SOLUTIONS FOR THE PREPARATION OF CERUMENOLITICAL MEDICINES.
WO1996040058A3 (en) Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
SE7906037L (en) STERILISATIONSSYSTEM
US20030035849A1 (en) Topically applied synthetic ocean water mixture and method of using same
ES2134920T3 (en) AQUEOUS COMPOSITIONS OF A STRONG ACID CHARACTER, STABLE, CONTAINING PERSULFATE SALTS.
Zhang et al. EFFECT OF FLUORIDE ANION ON ANODIC POLARIZATION BEHAVIOR OF TITANIUM IN SODIUM BROMIDE SOLUTION(Chinese)
Henning et al. Multiple mechanisms for antiarrhythmic drug action on delayed afterdepolarizations and triggered activity in canine coronary sinus
Burgen Symposium on Membrane Transport [Abridged] The Effect of Drugs on Membrane Transport
Psomadakis et al. Experience with isoxsuprine in the treatment of sickle cell crisis: a proposed mechanism of action
Spealman The action of osmotically-active substances on the heart rate
Hewett et al. β Adrenergic modulation of digitalis-induced delayed afterdepolarizations and triggered activity
RU93014293A (en) METHOD OF TREATMENT OF CHRONIC BRONCHITIS
Härtl et al. Effect of hypertonic-hyperoncotic solutions (HHS) on increased intracranial pressure after a focal brain lesion and inflation of an epidural balloon
GB1383118A (en) Sterilising agent
e Silva Jr et al. INTRA-AORTIC INFUSIONS OF HYPERTONIC NaCl DO NOT REVERSE HYPOVOLEMIC SHOCK